Contract SPE2DE21F0099
Abbott Rapid Dx North America Llc · Department Of Defense · November 25, 2020
Abbott Rapid Dx North America Llc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on November 25, 2020 for $9.68 million of work in in-vitro diagnostic substance manufacturing. Performance is in Orlando, FL. This is a task or delivery order issued under parent IDIQ SPE2DE20D0027. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 14, 2021.
Contract details
- PIID
- SPE2DE21F0099
- Parent IDIQ
- SPE2DE20D0027
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Orlando, FL
- First action
- November 25, 2020
- Latest action
- May 14, 2021
Description
8507827082!BINAXNOW COVID-19 AG CARD 40C
Modification timeline
-
May 14, 2021Mod P00002$-7.4K
-
December 22, 2020Mod P00001$-842.0K
-
November 25, 2020Base award$10.53M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2DE21F0099?
Contract SPE2DE21F0099 is a federal contract awarded to Abbott Rapid Dx North America Llc by Department Of Defense on November 25, 2020 for $9.68 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract SPE2DE21F0099?
Abbott Rapid Dx North America Llc won contract SPE2DE21F0099 from Department Of Defense.
How much is contract SPE2DE21F0099 worth?
Contract SPE2DE21F0099 has obligated $9.68 million to date.